安测健康珠江团队2020半年度工作会议召开院士团队齐出席

2020-07-20 16:15
2020年7月11日至13日,鉴于防疫的要求,易特科(安测健康)肺癌AI-CAD项目半年度工作会议在易特科集团深圳总部、沈阳分部和西安分部三个研发中心联网召开。易特科集团(安测健康)董事长兼CEO张贯京先生主持召开本次会议,我司珠江团队科学家钱唯院士、郑斌院士和姚育东院士、赵明芳教授、马贺教授、齐守良教授出席了本次会议并分别发表了相关专题报告。易特科集团(安测健康)副董事长肖应芬女士、联合创始人兼CTO葛新科博士、执行总裁梁艳妮女士、技术总监苏超英先生、总工程师张红治博士、战略合作业务总监赵立先生、投资总监张悦女士、投资关系总监杨博函女士和总裁助理陈匆女士以及AI-CAD研发小组全体成员等核心团队全程参加了会议,听取了AI-CAD研发小组总监唐苏明博士等医学AI技术研发团队的肺癌AI-CAD项目半年工作汇报,认真总结了上半年的工作,并对于下半年工作规划做了细致部署。

本次会议聚焦智能肺癌AI-CAD诊断、与癌症机理密切相关的医学影像、AI模型构建等主题。会议首先由姚育东院士对前一阶段项目工作的进展进行了回顾总结,随后项目组总监唐博士对项目的阶段性工作成果进行了展示陈述、马教授和齐教授对项目指标完成情况和下半年工作计划做了详尽的工作报告,之后院士科学家团队探讨了AI-CAD肿瘤影像学领域的新理论、新知识、新技术,交流和展示了肿瘤影像学领域近期取得的新进展,并分享了各自的最新研究成果和独到的心得体会,为大家带来了一场学术上的饕餮盛宴!

最后张贯京董事长总结指出,本次会议聚焦AI在肿瘤诊断和肿瘤治疗的各学科前沿研究和应用,为今后安测健康研发团队抓紧研发多模态肿瘤医疗影像智能分析及辅助诊断系统指明了方向,必将带动易特科(安测健康)新一轮医学影像研发的发展与变革。易特科(安测健康)将以不断进取的创新能力和优质的服务,在慢病管理、医学影像、肿瘤筛查等方面发挥积极作用,赢得更多未来!

院士科学家团队也充分肯定了易特科(安测健康)院士工作站的建设成效,同时对我司在智慧医疗健康领域取得的成绩表示赞赏,并表示将对易特科(安测健康)的学科建设和创新研发给予进一步的关注、支持和帮助,共同助力健康中国建设!

From July 11 to 13, 2020, in view of the requirements of epidemic prevention, the semi annual working meeting of E-techco (Anycheck health) lung cancer AI-CAD project was held online in three R & D centers of E-techco group, namely Shenzhen headquarters, Shenyang branch and Xi'an Branch. Mr. Zhang guanjing, chairman and CEO of E-techco group (Anycheck health), presided over the meeting. Academicians Qian Wei, Zheng bin, Yao Yudong, Zhao Mingfang, Ma He and Qi Shouliang, scientists of the Pearl River team of our company, attended the meeting and published relevant special reports. Ms. Xiao Yingfen, vice chairman of E-techco group (Anycheck health), Dr. Ge Xinke, co-founder and CTO, Ms. Liang Yanni, CEO, Mr. Su Chaoying, technical director, Dr. Zhang Hongzhi, chief engineer, Mr. Zhao Li, director of strategic cooperation business, Ms. Zhang Yue, investment director, Ms. Yang Bohan, director of investment relations and Ms. Chen Cong, assistant to the president, and all AI-CAD R & D team Members and other core teams attended the whole meeting, listened to the half year work report of lung cancer AI-CAD project of medical AI technology research and development team such as Dr. Tang suming, director of AI-CAD R & D group, and conscientiously summarized the work of the first half of the year, and made detailed arrangements for the work planning of the second half of the year.
The conference focused on AI-CAD intelligent diagnosis of lung cancer, medical imaging closely related to cancer mechanism, and AI model construction. At the meeting, academician Yao Yudong reviewed and summarized the progress of the previous phase of the project, and then Dr. Tang, director of the project team, presented the phased work results of the project. Professor Ma and Professor Qi made a detailed work report on the completion of the project indicators and the work plan for the second half of the year. After that, the academician and scientist team discussed the new developments in the field of AI-CAD oncology The theory, new knowledge, new technology, exchange and display the new progress in the field of tumor imaging, and share their latest research results and unique experience, which brings us a feast of academic feast!
Finally, chairman Zhang guanjing concluded that the meeting focused on the frontier research and application of AI in various disciplines of tumor diagnosis and treatment, which pointed out the direction for the future safety testing and health research and development team to pay close attention to the development of multimodal tumor medical imaging intelligent analysis and auxiliary diagnosis system, and will certainly drive the development and reform of a new round of medical imaging research and development of E-techco (Anycheck health). E-techco (safety test health) will play an active role in chronic disease management, medical imaging, tumor screening and other aspects with continuous innovation ability and high-quality service, so as to win more future!
The team of academicians and scientists also fully affirmed the achievements of E-techco (Anycheck health) academician workstation, appreciated the achievements of our company in the field of intelligent medical and health, and said that it would pay further attention, support and help to the discipline construction and innovative research and development of E-techco (Anycheck health), so as to jointly help the construction of healthy China!